Home › Companies › AnaptysBio, Inc. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AnaptysBio, Inc.’s Form 8-K, filed June 17, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 17, 2025: 6 items on AnaptysBio, Inc.’s Form 8-K, filed June 17, 2025: 6 passed (calculated).
Significant dissent: 1 equity or compensation plan (26.1% against).
Notable dissent: 2 directors (18.1%, 15.8% against); 1 say-on-pay vote (73.0% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025
Activist investors: Tang Capital (13F, 4.9%, as of September 30, 2026) · Irenic Capital (13F, 1.0%, as of September 30, 2026)
Explore AnaptysBio, Inc. in the interactive database Compare manager voting policies
These tallies are AnaptysBio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Rita Jain, M.D. | 23,913,554 | -- | -- | 1,763,097 | 1,589,342 | 93% | Passed (calculated) | — |
| Elect Director: John Orwin | 21,616,016 | -- | -- | 4,060,635 | 1,589,342 | 84% | Passed (calculated) | — |
| Elect Director: J. Anthony Ware, M.D. | 21,035,965 | -- | -- | 4,640,686 | 1,589,342 | 82% | Passed (calculated) | — |
| 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 27,248,166 | 17,021 | 806 | -- | -- | 99.9% | Passed (calculated) | — |
| 3. Non-binding, advisory approval of compensation paid to the Company's named executive officers | 17,781,545 | 6,590,193 | 1,304,913 | -- | 1,589,342 | 73% | Passed (calculated) | — |
| 4. Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan | 18,017,143 | 6,354,718 | 1,304,790 | -- | 1,589,342 | 74% | Passed (calculated) | — |
Source: AnaptysBio, Inc., Form 8-K, filed with the SEC on June 17, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
184 asset managers disclosed a vote on at least one AnaptysBio, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AnaptysBio, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: J. Anthony Ware, M.D.
AnaptysBio, Inc.’s own tally for this item (“Elect Director: J. Anthony Ware, M.D.”): 21,035,965 for, 4,640,686 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 1,746,056 for, 1,183,352 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 554,358 | 0 | 0 | 0 | For |
| T. Rowe Price | 495,111 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 393,769 | Withhold |
| Vanguard | 246,436 | 0 | 0 | 400 | For |
| Bridge Builder Trust | 4,180 | 0 | 0 | 237,430 | Withhold |
| Fidelity | 20,956 | 0 | 0 | 169,648 | Mixed |
| Charles Schwab | 154,290 | 0 | 0 | 0 | For |
| State Street | 131,614 | 0 | 0 | 170 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 128,979 | Withhold |
| TIAA | 95,968 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 93,732 | Withhold |
| Equitable | 3,858 | 0 | 0 | 30,320 | Mixed |
| Jackson National | 0 | 0 | 0 | 33,320 | Withhold |
| Northern Trust | 0 | 0 | 0 | 18,214 | Withhold |
| Lincoln Financial | 15,600 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 11,284 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 11,042 | Withhold |
| Federated Hermes | 7,913 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 7,490 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 7,427 | Withhold |
| Pacific Life | 7,229 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 6,034 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 5,485 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 5,088 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 4,424 | Withhold |
Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: John Orwin
AnaptysBio, Inc.’s own tally for this item (“Elect Director: John Orwin”): 21,616,016 for, 4,060,635 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 1,905,216 for, 1,024,192 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 554,358 | 0 | 0 | 0 | For |
| T. Rowe Price | 495,111 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 393,769 | Withhold |
| Vanguard | 246,436 | 0 | 0 | 400 | For |
| Bridge Builder Trust | 4,180 | 0 | 0 | 237,430 | Withhold |
| Fidelity | 20,956 | 0 | 0 | 169,648 | Mixed |
| Charles Schwab | 154,290 | 0 | 0 | 0 | For |
| State Street | 131,614 | 0 | 0 | 170 | For |
| FRANKLIN STRATEGIC SERIES | 128,979 | 0 | 0 | 0 | For |
| TIAA | 95,968 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 93,732 | Withhold |
| Equitable | 3,858 | 0 | 0 | 30,320 | Mixed |
| Jackson National | 0 | 0 | 0 | 33,320 | Withhold |
| Northern Trust | 18,214 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,600 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 11,284 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 11,042 | Withhold |
| Federated Hermes | 7,913 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 7,490 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 7,427 | Withhold |
| Pacific Life | 7,229 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 6,034 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 5,485 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 5,088 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 4,424 | Withhold |
Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Rita Jain, M.D.
AnaptysBio, Inc.’s own tally for this item (“Elect Director: Rita Jain, M.D.”): 23,913,554 for, 1,763,097 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 2,145,495 for, 783,913 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,110 | 0 | 0 | 553,248 | Withhold |
| T. Rowe Price | 495,111 | 0 | 0 | 0 | For |
| Victory Capital | 393,769 | 0 | 0 | 0 | For |
| Vanguard | 246,836 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 237,430 | 0 | 0 | 4,180 | For |
| Fidelity | 13,827 | 0 | 0 | 176,777 | Mixed |
| Charles Schwab | 154,290 | 0 | 0 | 0 | For |
| State Street | 131,784 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 128,979 | 0 | 0 | 0 | For |
| TIAA | 95,968 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 93,732 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 34,178 | Withhold |
| Jackson National | 33,320 | 0 | 0 | 0 | For |
| Northern Trust | 18,214 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,600 | 0 | 0 | 0 | For |
| ProShares | 11,284 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,042 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 7,913 | Withhold |
| ETFis Series Trust I | 7,490 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 7,427 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 0 | 7,229 | Withhold |
| Brighthouse | 6,034 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 5,485 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 5,088 | 0 | 0 | 0 | For |
| John Hancock | 4,424 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Prior year: 78.2% for (June 12, 2024 meeting) ▼ 4.3 pts
Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR 2017 EQUITY INCENTIVE PLAN.
AnaptysBio, Inc.’s own tally for this item (“4. Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan”): 18,017,143 for, 6,354,718 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 74% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 554,358 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 495,111 | 0 | 0 | Against |
| Victory Capital | 0 | 393,769 | 0 | 0 | Against |
| Vanguard | 0 | 246,836 | 0 | 0 | Against |
| Bridge Builder Trust | 4,180 | 237,430 | 0 | 0 | Against |
| Fidelity | 7,629 | 182,975 | 0 | 0 | Against |
| Charles Schwab | 0 | 154,290 | 0 | 0 | Against |
| State Street | 313 | 131,471 | 0 | 0 | Against |
| FRANKLIN STRATEGIC SERIES | 0 | 128,979 | 0 | 0 | Against |
| TIAA | 0 | 95,968 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 93,732 | 0 | 0 | Against |
| Equitable | 3,858 | 30,320 | 0 | 0 | Mixed |
| Jackson National | 0 | 33,320 | 0 | 0 | Against |
| Northern Trust | 0 | 18,214 | 0 | 0 | Against |
| Lincoln Financial | 0 | 15,600 | 0 | 0 | Against |
| ProShares | 0 | 11,284 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 11,042 | 0 | 0 | Against |
| Federated Hermes | 0 | 7,913 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 7,490 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 7,427 | 0 | 0 | Against |
| Pacific Life | 7,229 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 6,034 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 5,485 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 5,088 | 0 | 0 | 0 | For |
| John Hancock | 0 | 4,424 | 0 | 0 | Against |
Fund voting reports, all 47 managers: 582,697 for, 2,346,711 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 7,880,094 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 4,111,731 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 0 | 2,709 | 0 | 0 | Against |
Institutional-manager reports, all 3 managers: 11,991,825 for, 2,709 against.
Combines 7 wordings of this item as funds reported it.
73% Majority: yes · of votes cast
Prior year: 87.1% for (June 12, 2024 meeting) ▼ 14.1 pts
Description as filed by funds: To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials.
AnaptysBio, Inc.’s own tally for this item (“3. Non-binding, advisory approval of compensation paid to the Company's named executive officers”): 17,781,545 for, 6,590,193 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 73% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,110 | 553,248 | 0 | 0 | Against |
| T. Rowe Price | 0 | 495,111 | 0 | 0 | Against |
| Victory Capital | 0 | 393,769 | 0 | 0 | Against |
| Vanguard | 246,436 | 400 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 241,610 | 0 | 0 | Against |
| Fidelity | 0 | 190,604 | 0 | 0 | Against |
| Charles Schwab | 0 | 154,290 | 0 | 0 | Against |
| State Street | 131,442 | 342 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 128,979 | 0 | 0 | Against |
| TIAA | 0 | 95,968 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 93,732 | 0 | 0 | Against |
| Equitable | 0 | 34,178 | 0 | 0 | Against |
| Jackson National | 0 | 33,320 | 0 | 0 | Against |
| Northern Trust | 18,214 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,600 | 0 | 0 | 0 | For |
| ProShares | 0 | 11,284 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 11,042 | 0 | 0 | Against |
| FORUM FUNDS II | 0 | 8,150 | 0 | 0 | Against |
| Federated Hermes | 0 | 7,913 | 0 | 0 | Against |
| ETFis Series Trust I | 0 | 7,490 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 7,427 | 0 | 0 | Against |
| Pacific Life | 0 | 7,229 | 0 | 0 | Against |
| Brighthouse | 0 | 6,034 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 5,485 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 5,088 | 0 | 0 | 0 | For |
Fund voting reports, all 48 managers: 419,297 for, 2,518,261 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 7,880,094 | 0 | 0 | 0 | For |
| First Light Asset Management, LLC | 4,111,731 | 0 | 0 | 0 | For |
| Point72 | 1,719,746 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 0 | 813,516 | 0 | 0 | Against |
| Palo Alto Investors LP | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 760,770 | 0 | 0 | 0 | For |
| Camber Capital Management LP | 0 | 750,000 | 0 | 0 | Against |
| T. Rowe Price | 0 | 718,426 | 0 | 0 | Against |
| Victory Capital | 0 | 651,085 | 0 | 0 | Against |
| BlackRock | 96,329 | 454,093 | 0 | 0 | Mixed |
| Fidelity | 0 | 537,165 | 0 | 0 | Against |
| 5AM Venture Management, LLC | 357,733 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 0 | 354,370 | 0 | 0 | Against |
| State Street | 332,438 | 2,179 | 0 | 0 | For |
| Madison Avenue Partners, LP | 291,788 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 215,454 | 0 | 0 | 0 | For |
| Citadel | 179,035 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 154,290 | 0 | 0 | Against |
| Northern Trust | 114,470 | 4,299 | 0 | 0 | For |
| Opaleye Management Inc. | 98,674 | 0 | 0 | 0 | For |
| Exome Asset Management LLC | 97,696 | 0 | 0 | 0 | For |
| Nuveen | 0 | 96,998 | 0 | 0 | Against |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 93,732 | 0 | 0 | Against |
| Renaissance | 0 | 91,475 | 0 | 0 | Against |
| Allianz | 0 | 90,945 | 0 | 0 | Against |
Institutional-manager reports, all 149 managers: 16,414,117 for, 5,490,571 against, 806,346 unknown, 6,028 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Non-binding advisory vote on the frequency of holding future advisory votes regarding named executive officer compensation.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Delaware/Macquarie | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| ETFis Series Trust I | 0 | 0 | 0 | 0 | -- |
| ALPS ETF Trust | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 47 managers: 2,929,408 1 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 4,111,731 | 0 | 0 | 0 | For |
| Point72 | 0 | 0 | 0 | 0 | -- |
| Sofinnova Investments, Inc. | 0 | 0 | 0 | 0 | -- |
| Palo Alto Investors LP | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| Camber Capital Management LP | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| 5AM Venture Management, LLC | 0 | 0 | 0 | 0 | -- |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Madison Avenue Partners, LP | 0 | 0 | 0 | 0 | -- |
| Ensign Peak Advisors, Inc | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Allianz | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 139 managers: 4,112,951 for, 6,159 against, 9,384,923 1 year, 806,346 unknown, 218,289 3 year. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Majority: yes · of votes cast
Prior year: 99.9% for (June 12, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
AnaptysBio, Inc.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 27,248,166 for, 17,021 against, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 2,929,054 for, 354 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 554,358 | 0 | 0 | 0 | For |
| T. Rowe Price | 495,111 | 0 | 0 | 0 | For |
| Victory Capital | 393,769 | 0 | 0 | 0 | For |
| Vanguard | 246,836 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 241,610 | 0 | 0 | 0 | For |
| Fidelity | 190,604 | 0 | 0 | 0 | For |
| Charles Schwab | 154,290 | 0 | 0 | 0 | For |
| State Street | 131,776 | 8 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 128,979 | 0 | 0 | 0 | For |
| TIAA | 95,968 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 93,732 | 0 | 0 | 0 | For |
| Equitable | 34,178 | 0 | 0 | 0 | For |
| Jackson National | 33,320 | 0 | 0 | 0 | For |
| Northern Trust | 18,214 | 0 | 0 | 0 | For |
| Lincoln Financial | 15,600 | 0 | 0 | 0 | For |
| ProShares | 11,284 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 11,042 | 0 | 0 | 0 | For |
| Federated Hermes | 7,913 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 7,490 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 7,427 | 0 | 0 | 0 | For |
| Pacific Life | 7,229 | 0 | 0 | 0 | For |
| Brighthouse | 6,034 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 5,485 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 5,088 | 0 | 0 | 0 | For |
| John Hancock | 4,424 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. All 47 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 30,387,893 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 1.82% |
| 2 | T. Rowe Price | 1.63% |
| 3 | Victory Capital | 1.30% |
| 4 | Vanguard | 0.81% |
| 5 | Bridge Builder Trust | 0.80% |
| 6 | Fidelity | 0.63% |
| 7 | Charles Schwab | 0.51% |
| 8 | State Street | 0.43% |
| 9 | FRANKLIN STRATEGIC SERIES | 0.42% |
| 10 | TIAA | 0.32% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | EcoR1 Capital, LLC | 25.93% |
| 2 | First Light Asset Management, LLC | 13.53% |
| 3 | Point72 | 5.66% |
| 4 | Sofinnova Investments, Inc. | 2.68% |
| 5 | Palo Alto Investors LP | 2.65% |
| 6 | Woodline Partners LP | 2.50% |
| 7 | Camber Capital Management LP | 2.47% |
| 8 | T. Rowe Price | 2.36% |
| 9 | Victory Capital | 2.14% |
| 10 | BlackRock | 1.81% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| EcoR1 Capital LLC | 7,880,094 | — | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| Oleg Nodelman | 7,880,094 | — | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| First Light Asset Management, LLC | 4,653,068 | — | Schedule 13G, filed March 7, 2025 |
| FMR LLC | 2,870,618 | — | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| Point72 | 2,368,370 | — | Form 13F, quarter ended March 31, 2025 |
| BlackRock | 2,176,598 | — | Form 13F, quarter ended March 31, 2025 |
| FMR (Fidelity) | 1,905,154 | — | Form 13F, quarter ended March 31, 2025 |
| Point72 Asset Management, L.P. | 1,691,372 | — | Proxy statement (DEF 14A), proxy filed April 29, 2025 |
| James N. Topper | 1,655,295 | — | Schedule 13G, filed February 14, 2025 |
| Vanguard Group | 1,517,325 | — | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 30,387,893 shares outstanding, as reported by AnaptysBio, Inc. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At AnaptysBio, Inc.'s shareholder meeting held June 17, 2025, in the 2024-2025 proxy season, 184 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,422 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To conduct a non-binding advisory vote on the compensation of our named executive officers as… — FOR was 73% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AnaptysBio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AnaptysBio, Inc.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
AnaptysBio, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page).
Proxy Votes Now, “AnaptysBio (ANAB) 2025 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/anaptysbio-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.